Medical research scientist joins the Partnership of Shelston IP
Published on 01 Jan, 2015
Shelston IP is proud to announce patent attorney Grant Shoebridge has been promoted to Partner, effective 1 January 2015.
Grant joined Shelston IP in 2006 and was promoted to Senior Associate in 2013.
Grant has almost a decade of experience in pharmaceutical and biotechnology-related intellectual property. He specialises in drafting, prosecution and opposition matters relating to molecular biology, cell biology,immunology, pharmaceuticals, medical devices, agricultural technology, and diagnostic technology. Grant also has particular expertise in securing extensions of term on pharmaceutical patents, advising on patent validity and infringement, and Federal Court litigation matters.
Prior to entering the intellectual property profession, Grant accrued almost 20 years’ experience working as a research scientist with world-class institutions including Sydney’s Royal Prince Alfred Hospital (where he successfully developed a novel HIV diagnostic assay and investigated metastasis of breast cancer), London’s Institute of Psychiatry (where he investigated Alzheimer’s disease), the Institut de Biochimie in Switzerland, and Sydney’s Centenary Institute of Cancer Medicine and Cell Biology (where he worked on the development of a DNA vaccine against tuberculosis).
Grant is passionate about intellectual property and the crucial role it plays in bringing innovation from the laboratory to the public in the form of new medicines, treatments and diagnostics.